Bicycle Therapeutics plc
BCYC
$7.12
$0.020.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.56% | -20.85% | 6.44% | -2.93% | -18.13% |
| Total Depreciation and Amortization | 8.49% | 7.57% | 9.59% | 13.48% | 13.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.53% | -21.24% | -16.96% | 6.95% | 90.77% |
| Change in Net Operating Assets | 92.79% | -137.88% | -143.63% | -197.14% | -171.73% |
| Cash from Operations | -27.21% | -111.82% | -171.70% | -364.19% | -237.79% |
| Capital Expenditure | -93.40% | -116.98% | 57.84% | 78.78% | 85.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -93.40% | -116.98% | 57.84% | 78.78% | 85.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.97% | 120.66% | 120.66% | 115.97% | 3,635.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.04% | 107.82% | 107.88% | 103.47% | 3,635.07% |
| Foreign Exchange rate Adjustments | 1,086.04% | -60.17% | -151.56% | -34.20% | -111.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.60% | 105.20% | 88.00% | 50.96% | 2,021.94% |